“It is my aspiration that health finally will be seen not as a blessing to be wished for, but as a human right to be fought for.” – United Nations Secretary-General Kofi Annan
In this edition, we are excited to share news about our companies-in-residence who are “fighting” every day to bring better healthcare to patients globally.
Among these companies are three new startups targeting women’s healthcare that were just accepted into the Institute: Igantia Therapeutics, Marz Medical and Madorra. These early-stage companies are following in the footsteps of two graduating companies, InterVene and Prescient Surgical, which successfully graduated from the Institute with a strong round of funding.
We are also proud to announce the launch of the Ferolyn Fund as a tribute to Ferolyn Powell’s invaluable contributions to the medtech industry. Ferolyn embodied the spirit of raising the bar for better patient care, both as a CEO at Evalve and as a mentor to young medtech entrepreneurs.
President and Chief Executive Officer